世界の革新的医薬品市場2020年:企業別、地域別、種類・用途別

【英語タイトル】Global Innovative Drug Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20SP03923)・商品コード:GIR20SP03923
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年9月18日(※2024年版があります。お問い合わせください)
・ページ数:127
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、革新的医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。革新的医薬品の種類別市場規模(生物医薬品、化学医薬品)、用途別市場規模(病院、診療所、薬局、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Pfizer、Gilead Sciences、Johnson & Johnson、Roche、AbbVie、Sanofi、Amgen、Novartis、Merck & Co. (MSD)、GlaxoSmithKline (GSK)、Bayer、Takeda、AstraZeneca、Novo Nordisk、Teva、Bristol-Myers Squibb、Boehringer Ingelheim、Allergan、Eli Lilly
・地域別グローバル市場分析 2015年-2020年
・革新的医薬品の北米市場(アメリカ、カナダ、メキシコ)
・革新的医薬品のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・革新的医薬品のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・革新的医薬品の南米市場(ブラジル、アルゼンチン)
・革新的医薬品の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:生物医薬品、化学医薬品
・用途別分析:病院、診療所、薬局、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The Innovative Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Innovative Drug sales will be xx in 2020 from Innovative Drug million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Innovative Drug market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Innovative Drug industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Innovative Drug and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Innovative Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Innovative Drug market has been segmented into:
Biological Medicine
Chemical Medicine

By Application, Innovative Drug has been segmented into:
Hospitals and Clinics
Pharmacy
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Innovative Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Innovative Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Innovative Drug market.

The report offers in-depth assessment of the growth and other aspects of the Innovative Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Innovative Drug Market Share Analysis
Innovative Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Innovative Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Innovative Drug sales, revenue and market share for each player covered in this report.

The major players covered in Innovative Drug are:
Pfizer
Gilead Sciences
Johnson & Johnson
Roche
AbbVie
Sanofi
Amgen
Novartis
Merck & Co. (MSD)
GlaxoSmithKline (GSK)
Bayer
Takeda
AstraZeneca
Novo Nordisk
Teva
Bristol-Myers Squibb
Boehringer Ingelheim
Allergan
Eli Lilly
Among other players domestic and global, Innovative Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 Innovative Drug Market Overview
1.1 Product Overview and Scope of Innovative Drug
1.2 Classification of Innovative Drug by Type
1.2.1 Global Innovative Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Innovative Drug Revenue Market Share by Type in 2019
1.2.3 Biological Medicine
1.2.4 Chemical Medicine
1.3 Global Innovative Drug Market by Application
1.3.1 Overview: Global Innovative Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Innovative Drug Market by Regions
1.4.1 Global Innovative Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Innovative Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Innovative Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Innovative Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Innovative Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Innovative Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Innovative Drug Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Innovative Drug Industry Impact
1.5.1 COVID-19 Potential Implications for the Innovative Drug
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Innovative Drug
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Gilead Sciences SWOT Analysis
2.2.4 Gilead Sciences Product and Services
2.2.5 Gilead Sciences Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AbbVie SWOT Analysis
2.5.4 AbbVie Product and Services
2.5.5 AbbVie Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amgen SWOT Analysis
2.7.4 Amgen Product and Services
2.7.5 Amgen Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck & Co. (MSD)
2.9.1 Merck & Co. (MSD) Details
2.9.2 Merck & Co. (MSD) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck & Co. (MSD) SWOT Analysis
2.9.4 Merck & Co. (MSD) Product and Services
2.9.5 Merck & Co. (MSD) Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline (GSK)
2.10.1 GlaxoSmithKline (GSK) Details
2.10.2 GlaxoSmithKline (GSK) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline (GSK) SWOT Analysis
2.10.4 GlaxoSmithKline (GSK) Product and Services
2.10.5 GlaxoSmithKline (GSK) Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bayer
2.11.1 Bayer Details
2.11.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bayer SWOT Analysis
2.11.4 Bayer Product and Services
2.11.5 Bayer Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Takeda SWOT Analysis
2.12.4 Takeda Product and Services
2.12.5 Takeda Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 AstraZeneca SWOT Analysis
2.13.4 AstraZeneca Product and Services
2.13.5 AstraZeneca Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.14 Novo Nordisk
2.14.1 Novo Nordisk Details
2.14.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Novo Nordisk SWOT Analysis
2.14.4 Novo Nordisk Product and Services
2.14.5 Novo Nordisk Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.15 Teva
2.15.1 Teva Details
2.15.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Teva SWOT Analysis
2.15.4 Teva Product and Services
2.15.5 Teva Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.16 Bristol-Myers Squibb
2.16.1 Bristol-Myers Squibb Details
2.16.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Bristol-Myers Squibb SWOT Analysis
2.16.4 Bristol-Myers Squibb Product and Services
2.16.5 Bristol-Myers Squibb Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.17 Boehringer Ingelheim
2.17.1 Boehringer Ingelheim Details
2.17.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Boehringer Ingelheim SWOT Analysis
2.17.4 Boehringer Ingelheim Product and Services
2.17.5 Boehringer Ingelheim Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.18 Allergan
2.18.1 Allergan Details
2.18.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Allergan SWOT Analysis
2.18.4 Allergan Product and Services
2.18.3 Allergan Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
2.19 Eli Lilly
2.19.1 Eli Lilly Details
2.19.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Eli Lilly SWOT Analysis
2.19.4 Eli Lilly Product and Services
2.19.5 Eli Lilly Innovative Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Innovative Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Innovative Drug Players Market Share
3.2.2 Top 10 Innovative Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Innovative Drug Revenue and Market Share by Regions
4.2 North America Innovative Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Innovative Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Innovative Drug Revenue and Growth Rate (2015-2020)
4.5 South America Innovative Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Innovative Drug Revenue and Growth Rate (2015-2020)
5 North America Innovative Drug Revenue by Countries
5.1 North America Innovative Drug Revenue by Countries (2015-2020)
5.2 USA Innovative Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Innovative Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Innovative Drug Revenue and Growth Rate (2015-2020)
6 Europe Innovative Drug Revenue by Countries
6.1 Europe Innovative Drug Revenue by Countries (2015-2020)
6.2 Germany Innovative Drug Revenue and Growth Rate (2015-2020)
6.3 UK Innovative Drug Revenue and Growth Rate (2015-2020)
6.4 France Innovative Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Innovative Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Innovative Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Innovative Drug Revenue by Countries
7.1 Asia-Pacific Innovative Drug Revenue by Countries (2015-2020)
7.2 China Innovative Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Innovative Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Innovative Drug Revenue and Growth Rate (2015-2020)
7.5 India Innovative Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Innovative Drug Revenue and Growth Rate (2015-2020)
8 South America Innovative Drug Revenue by Countries
8.1 South America Innovative Drug Revenue by Countries (2015-2020)
8.2 Brazil Innovative Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Innovative Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Innovative Drug by Countries
9.1 Middle East & Africa Innovative Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Innovative Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Innovative Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Innovative Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Innovative Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Innovative Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Innovative Drug Market Forecast by Type (2019-2024)
10.3 Biological Medicine Revenue Growth Rate (2015-2025)
10.4 Chemical Medicine Revenue Growth Rate (2015-2025)
11 Global Innovative Drug Market Segment by Application
11.1 Global Innovative Drug Revenue Market Share by Application (2015-2020)
11.2 Innovative Drug Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Pharmacy Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Innovative Drug Market Size Forecast (2021-2025)
12.1 Global Innovative Drug Market Size Forecast (2021-2025)
12.2 Global Innovative Drug Market Forecast by Regions (2021-2025)
12.3 North America Innovative Drug Revenue Market Forecast (2021-2025)
12.4 Europe Innovative Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Innovative Drug Revenue Market Forecast (2021-2025)
12.6 South America Innovative Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Innovative Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Innovative Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Innovative Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Innovative Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Innovative Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Innovative Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Pfizer Corporate Information, Location and Competitors
Table 7. Pfizer Innovative Drug Major Business
Table 8. Pfizer Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 9. Pfizer SWOT Analysis
Table 10. Pfizer Innovative Drug Product and Solutions
Table 11. Pfizer Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Gilead Sciences Corporate Information, Location and Competitors
Table 13. Gilead Sciences Innovative Drug Major Business
Table 14. Gilead Sciences Innovative Drug Total Revenue (USD Million) (2018-2019)
Table 15. Gilead Sciences SWOT Analysis
Table 16. Gilead Sciences Innovative Drug Product and Solutions
Table 17. Gilead Sciences Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Johnson & Johnson Corporate Information, Location and Competitors
Table 19. Johnson & Johnson Innovative Drug Major Business
Table 20. Johnson & Johnson Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 21. Johnson & Johnson SWOT Analysis
Table 22. Johnson & Johnson Innovative Drug Product and Solutions
Table 23. Johnson & Johnson Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Roche Corporate Information, Location and Competitors
Table 25. Roche Innovative Drug Major Business
Table 26. Roche Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 27. Roche SWOT Analysis
Table 28. Roche Innovative Drug Product and Solutions
Table 29. Roche Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. AbbVie Corporate Information, Location and Competitors
Table 31. AbbVie Innovative Drug Major Business
Table 32. AbbVie Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 33. AbbVie SWOT Analysis
Table 34. AbbVie Innovative Drug Product and Solutions
Table 35. AbbVie Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Sanofi Corporate Information, Location and Competitors
Table 37. Sanofi Innovative Drug Major Business
Table 38. Sanofi Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 39. Sanofi SWOT Analysis
Table 40. Sanofi Innovative Drug Product and Solutions
Table 41. Sanofi Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Amgen Corporate Information, Location and Competitors
Table 43. Amgen Innovative Drug Major Business
Table 44. Amgen Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 45. Amgen SWOT Analysis
Table 46. Amgen Innovative Drug Product and Solutions
Table 47. Amgen Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Novartis Corporate Information, Location and Competitors
Table 49. Novartis Innovative Drug Major Business
Table 50. Novartis Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 51. Novartis SWOT Analysis
Table 52. Novartis Innovative Drug Product and Solutions
Table 53. Novartis Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Merck & Co. (MSD) Corporate Information, Location and Competitors
Table 55. Merck & Co. (MSD) Innovative Drug Major Business
Table 56. Merck & Co. (MSD) Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 57. Merck & Co. (MSD) SWOT Analysis
Table 58. Merck & Co. (MSD) Innovative Drug Product and Solutions
Table 59. Merck & Co. (MSD) Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. GlaxoSmithKline (GSK) Corporate Information, Location and Competitors
Table 61. GlaxoSmithKline (GSK) Innovative Drug Major Business
Table 62. GlaxoSmithKline (GSK) Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 63. GlaxoSmithKline (GSK) SWOT Analysis
Table 64. GlaxoSmithKline (GSK) Innovative Drug Product and Solutions
Table 65. GlaxoSmithKline (GSK) Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Bayer Corporate Information, Location and Competitors
Table 67. Bayer Innovative Drug Major Business
Table 68. Bayer Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 69. Bayer SWOT Analysis
Table 70. Bayer Innovative Drug Product and Solutions
Table 71. Bayer Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Takeda Corporate Information, Location and Competitors
Table 73. Takeda Innovative Drug Major Business
Table 74. Takeda Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 75. Takeda SWOT Analysis
Table 76. Takeda Innovative Drug Product and Solutions
Table 77. Takeda Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. AstraZeneca Corporate Information, Location and Competitors
Table 79. AstraZeneca Innovative Drug Major Business
Table 80. AstraZeneca Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 81. AstraZeneca SWOT Analysis
Table 82. AstraZeneca Innovative Drug Product and Solutions
Table 83. AstraZeneca Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Novo Nordisk Corporate Information, Location and Competitors
Table 85. Novo Nordisk Innovative Drug Major Business
Table 86. Novo Nordisk Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 87. Novo Nordisk SWOT Analysis
Table 88. Novo Nordisk Innovative Drug Product and Solutions
Table 89. Novo Nordisk Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Teva Corporate Information, Location and Competitors
Table 91. Teva Innovative Drug Major Business
Table 92. Teva Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 93. Teva SWOT Analysis
Table 94. Teva Innovative Drug Product and Solutions
Table 95. Teva Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 97. Bristol-Myers Squibb Innovative Drug Major Business
Table 98. Bristol-Myers Squibb Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 99. Bristol-Myers Squibb SWOT Analysis
Table 100. Bristol-Myers Squibb Innovative Drug Product and Solutions
Table 101. Bristol-Myers Squibb Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 103. Boehringer Ingelheim Innovative Drug Major Business
Table 104. Boehringer Ingelheim Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 105. Boehringer Ingelheim SWOT Analysis
Table 106. Boehringer Ingelheim Innovative Drug Product and Solutions
Table 107. Boehringer Ingelheim Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Allergan Innovative Drug Type and Application
Table 109. Allergan Innovative Drug Major Business
Table 110. Allergan Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 111. Allergan SWOT Analysis
Table 112. Allergan Innovative Drug Product and Solutions
Table 113. Allergan Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Eli Lilly Corporate Information, Location and Competitors
Table 115. Eli Lilly Innovative Drug Major Business
Table 116. Eli Lilly Innovative Drug Total Revenue (USD Million) (2017-2018)
Table 117. Eli Lilly SWOT Analysis
Table 118. Eli Lilly Innovative Drug Product and Solutions
Table 119. Eli Lilly Innovative Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Global Innovative Drug Revenue (Million USD) by Players (2015-2020)
Table 121. Global Innovative Drug Revenue Share by Players (2015-2020)
Table 122. Global Innovative Drug Revenue (Million USD) by Regions (2015-2020)
Table 123. Global Innovative Drug Revenue Market Share by Regions (2015-2020)
Table 124. North America Innovative Drug Revenue by Countries (2015-2020)
Table 125. North America Innovative Drug Revenue Market Share by Countries (2015-2020)
Table 126. Europe Innovative Drug Revenue (Million USD) by Countries (2015-2020)
Table 127. Asia-Pacific Innovative Drug Revenue (Million USD) by Countries (2015-2020)
Table 128. South America Innovative Drug Revenue by Countries (2015-2020)
Table 129. South America Innovative Drug Revenue Market Share by Countries (2015-2020)
Table 130. Middle East and Africa Innovative Drug Revenue (Million USD) by Countries (2015-2020)
Table 131. Middle East and Africa Innovative Drug Revenue Market Share by Countries (2015-2020)
Table 132. Global Innovative Drug Revenue (Million USD) by Type (2015-2020)
Table 133. Global Innovative Drug Revenue Share by Type (2015-2020)
Table 134. Global Innovative Drug Revenue Forecast by Type (2021-2025)
Table 135. Global Innovative Drug Revenue by Application (2015-2020)
Table 136. Global Innovative Drug Revenue Share by Application (2015-2020)
Table 137. Global Innovative Drug Revenue Forecast by Application (2021-2025)
Table 138. Global Innovative Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Innovative Drug Picture
Figure 2. Global Innovative Drug Revenue Market Share by Type in 2019
Figure 3. Biological Medicine Picture
Figure 4. Chemical Medicine Picture
Figure 5. Innovative Drug Revenue Market Share by Application in 2019
Figure 6. Hospitals and Clinics Picture
Figure 7. Pharmacy Picture
Figure 8. Others Picture
Figure 9. Global Innovative Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Innovative Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Innovative Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Innovative Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Innovative Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Innovative Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Innovative Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Innovative Drug Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Innovative Drug Revenue Market Share in 2019
Figure 18. Global Top 10 Players Innovative Drug Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Innovative Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Innovative Drug Revenue Market Share by Regions (2015-2020)
Figure 22. Global Innovative Drug Revenue Market Share by Regions in 2018
Figure 23. North America Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 24. Europe Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 26. South America Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 28. North America Innovative Drug Revenue Market Share by Countries (2015-2020)
Figure 29. North America Innovative Drug Revenue Market Share by Countries in 2019
Figure 30. USA Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 31. Canada Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 33. Europe Innovative Drug Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Innovative Drug Revenue Market Share by Countries in 2019
Figure 35. Germany Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 36. UK Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 37. France Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 38. Russia Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 39. Italy Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Innovative Drug Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Innovative Drug Revenue Market Share by Countries in 2019
Figure 42. China Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 43. Japan Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 44. Korea Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 45. India Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 47. South America Innovative Drug Revenue Market Share by Countries (2015-2020)
Figure 48. South America Innovative Drug Revenue Market Share by Countries in 2019
Figure 49. Brazil Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Innovative Drug Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Innovative Drug Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 54. UAE Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Innovative Drug Revenue and Growth Rate (2015-2020)
Figure 57. Global Innovative Drug Revenue Share by Type (2015-2020)
Figure 58. Global Innovative Drug Revenue Share by Type in 2019
Figure 59. Global Innovative Drug Market Share Forecast by Type (2021-2025)
Figure 60. Global Biological Medicine Revenue Growth Rate (2015-2020)
Figure 61. Global Chemical Medicine Revenue Growth Rate (2015-2020)
Figure 62. Global Innovative Drug Revenue Share by Application (2015-2020)
Figure 63. Global Innovative Drug Revenue Share by Application in 2019
Figure 64. Global Innovative Drug Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 66. Global Pharmacy Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Innovative Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Innovative Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Innovative Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Innovative Drug Revenue Market Forecast (2021-2025)
Figure 72. Europe Innovative Drug Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Innovative Drug Revenue Market Forecast (2021-2025)
Figure 74. South America Innovative Drug Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Innovative Drug Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Pfizer、Gilead Sciences、Johnson & Johnson、Roche、AbbVie、Sanofi、Amgen、Novartis、Merck & Co. (MSD)、GlaxoSmithKline (GSK)、Bayer、Takeda、AstraZeneca、Novo Nordisk、Teva、Bristol-Myers Squibb、Boehringer Ingelheim、Allergan、Eli Lilly

★調査レポート[世界の革新的医薬品市場2020年:企業別、地域別、種類・用途別] (コード:GIR20SP03923)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の革新的医薬品市場2020年:企業別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆